The impact of HIV infection on tropical diseases

Infectious Disease Clinics of North America

Volumn 19, Issue 1, 2005, Pages 121-135

  Harms, Gundel ^a   Feldmeier, Hermann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY DERIVATIVE; ANTIRETROVIRUS AGENT; EFLORNITHINE; IVERMECTIN; MELARSOPROL;

AFRICAN TRYPANOSOMIASIS; CHAGAS DISEASE; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE TRANSMISSION; FILARIASIS; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; LEISHMANIASIS; MALARIA; MORBIDITY; MORTALITY; ONCHOCERCIASIS; REVIEW; RISK REDUCTION; SCHISTOSOMIASIS; SIDE EFFECT; SURVIVAL RATE; TH1 CELL; TH2 CELL; TROPICAL DISEASE; VIRUS LOAD;

EID: 13444273289     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2004.10.002     Document Type: Review

References (64)

1. G. Harms, and H. Feldmeier HIV infection and tropical parasitic diseases: deleterious interactions in both directions? Trop Med Int Health 7 2002 479 488
2. P.B. Bloland, J.J. Wirima, and R.W. Steketee Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection AIDS 9 1995 721 726
3. F.H. Verhoeff, B.J. Brabin, and C.A. Hart Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control Trop Med Int Health 4 1999 5 12
4. J.G. Ayisi, A.M. van Eijk, and F.O. ter Kuile The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya AIDS 17 2002 585 594
5. H. Brahmbhatt, G. Kigozi, and F. Wabwire-Mangen The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda AIDS 17 2003 2539 2541
6. V. Mwapasa, S.J. Rogerson, and M.E. Molyneux The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women AIDS 18 2004 1051 1059
7. J. Whitworth, D. Morgan, and M. Quigley Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study Lancet 23 2000 1051 1056
8. N.J. French, J. Nakiyingi, and E. Lugada Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults AIDS 15 2000 899 906
9. K. Grimwade, N. French, and D.D. Mbatha HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa AIDS 18 2004 547 554
10. I.E. Hoffman, C.S. Jere, and T.E. Taylor The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration AIDS 13 1999 487 494
11. S.L. Nathoo, L. Serghides, and K.C. Kain Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes Lancet 362 2003 1039 1041
12. H. Hunt, and G.E. Grau Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria Trends Immunol 24 2003 491 499
13. World Health Organization Leishmania/HIV co-infection, south-western Europe, 1990-1998 Wkly Epidemiol Rec 74 1999 365 375
14. P. Desjeux, and J. Alvar Leishmania/HIV co-infections: epidemiology in Europe Ann Trop Med Parasitol 97 2003 3 15
15. R. Bernier, B. Barbeau, and M.J. Trenblay The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor kB elements J Immunol 160 1998 2881 2888
16. J. Alvar, C. Canavate, and B. Gutierrez-Solar Leishmania and human immunodeficiency virus co-infection: the first ten years Clin Microbiol Rev 10 1997 298 319
17. R. Lopez-Velez, J.A. Perez-Molina, and A. Guerrero Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients co-infected with human immunodeficiency virus and leishmania in an area of Madrid, Spain Am J Trop Med Hyg 58 1998 436 443
18. E. Rosenthal, P. Marty, and Y. le Fichoux Clinical manifestation of visceral leishmaniasis associated with HIV-infection: a retrospective study of 91 French cases Ann Trop Med Parasitol 94 2000 37 42
19. V. Pintado, P. Martin-Rabadan, and M.L. Rivera Visceral leishmaniasis in HIV-infected and non-HIV-infected patients: a comparative study Medicine 80 2001 54 73
20. S. Bossolasco, G. Gaiera, and D. Olchini Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis J Clin Microbiol 41 2003 5080 5084
21. F. Laguna, S. Videla, and M.E. Jimenez-Mejias Amphotericin B lipid complex versus meglumine antimonite in the treatment of visceral leishmaniasis in patients infected with HIV: a randomised pilot study J Antimicrob Chemother 52 2003 464 468
22. J. Delgado, J. Macias, and J.A. Pineda High frequency of serious side effects from meglumine antimonite given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients Am J Trop Med Hyg 61 1999 766 769
23. M. Tumbarello, E. Tacconelli, and S. Bertagnolio Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals AIDS 14 2000 2948 2949
24. R. Lopez-Velez The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients co-infected with HIV Ann Trop Med Parasitol 97 2003 143 147
25. J.L. Villanueva, A. Alarcon, and M. Bernabeu-Wittel Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy Eur J Clin Microbiol Infect Dis 19 2000 798 801
26. R. Lopez-Velez, S. Videal, and M. Marquez Amphotericin B lipid complex versus treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients J Antimicrob Chemother 53 2004 540 543
27. F. Noireau, F. Brun-Vezinet, and B. Larouze Absence of relationship between human immunodeficiency virus 1 and sleeping sickness Trans R Soc Trop Med Hyg 81 1987 1000
28. J.P. Louis, J.P. Moulia-Pelat, and J. Jannin Absence of epidemiological inter-relations between HIV infection and African human trypanosomiasis in central Africa Trop Med Parasitol 42 1991 155
29. H.A. Meda, F. Doua, and C. Laveissiere Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Cote d'Ivoire Trans R Soc Trop Med Hyg 89 1995 639 643
30. J. Pepin, L. Ethier, and C. Kazadi The impact of immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioko, Zaire Am J Trop Med Hyg 47 1992 133 140
31. J. Blum, S. Nkunku, and C. Burri Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome and outcome during melarsoprol treatment of human African trypanosomiasis Trop Med Int Health 6 2001 390 400 Accessed May 23, 2004
32. World Health Organization 2003. http://www.who.int/ctd/chagas/burdens. htm.
33. L. Perez-Ramirez, C. Barnabe, and A.M. Sartori Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas disease coinfection in Brazil Am J Trop Med Hyg 61 1999 198 206
34. A.M. Sartori, J.E. Neto, and E.L. Visone Nunes Parasitemia in chronic Chagas' disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients J Infect Dis 186 2002 872 875
35. M.S. Ferreira, S.A. Nishioka, and M.T. Sivestre Reactivation of Chagas' disease in patients with AIDS: a report of three new cases and a review of the literature Clin Infect Dis 25 1997 1397 1400
36. R.S. Pacheco, M.S. Ferreira, and M.I. Machado Chagas' disease and HIV co-infection: genotypic characterisation of the Trypanosoma cruzi strain Mem Inst Oswaldo Cruz 93 1998 165 169
37. M.S. Ferreira, S.A. Nishioka, and A. Rocha Acute fatal Trypanosoma cruzi meningoencephalitis in a human immunodeficiency virus-positive hemo-philiac patient Am J Trop Med Hyg 45 1991 723 727
38. J.E. Cohen, E.C. Tsai, and H.J. Ginsberg Pseudotumoral chagasic meningoencephalitis as the first manifestation of AIDS Surg Neurol 49 1998 324 327
39. G.A. Di Lorenzo, M.A. Pagano, and A.L. Taratuto Chagasic granulomatous encephalitis in immunosuppressed patients J Neuroimaging 6 1996 94 97
40. A.M. Sartori, H.H. Caiaffa-Filho, and R.C. Bezerra Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease Am J Trop Med Hyg 67 2002 521 523
41. World Health Organization 2004. http://www.who.int/tdr/dw/schisto2004. htm. Accessed May 23, 2004
42. D.M. Karanja, A.W. Hightower, and D.G. Colley Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study Lancet 360 2002 592 596
43. P.N. Mwinzi, D.M. Karanja, and D.G. Colley Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection J Infect Dis 184 2001 488 496
44. D.M. Karanja, A.E. Boyer, and M. Strand Studies on schistosomiasis in western Kenya. II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with HIV-1 Am J Trop Med Hyg 59 1998 307 311
45. V. Mwanakasale, P. Vounatsou, and T.Y. Sukwa Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia Am J Trop Med Hyg 69 2003 420 428
46. H. Feldmeier, I. Krantz, and G. Poggensee Female genital schistosomiasis as a risk factor for the transmission of HIV Int J STD AIDS 5 1994 368 372
47. H. Feldmeier, G. Poggensee, I. Krantz, and G. Helling-Giese Female genital schistosomiasis: new challenge from a gender perspective Trop Geograph Med 47 1995 2 15
48. G. Poggensee, H. Feldmeier, and I. Krantz Schistosomiasis of the female genital tract: public health aspects Parasitol Today 15 1999 378 381
49. G. Poggensee, I. Kiwelu, and V. Wege Female genital schistosomiasis of the lower reproductive tract: prevalence and schistosome-related morbidity J Infect Dis 181 2000 1210 1213
50. V.R. Attili, S.K. Hira, and M.K. Dube Schistosomal genital granuloma: a report of 10 cases Br J Venerol Dis 59 1983 269 272
51. D. Mabey Interaction between HIV infection and other sexually transmitted diseases Trop Med Int Health 5 2000 32 36
52. G. Helling-Giese, A. Sjaastad, and G. Poggensee Female genital schistosomiasis (FGS): relationship between gynecological and histopathological findings Acta Trop 62 1996 257 267
53. M.B. Mosunjac, T. Tadros, and R. Beach Cervical schistosomiasis, human papilloma virus (HPV), and human immunodeficiency virus (HIV): a dangerous coexistence or coincidence? Gynecol Oncol 90 2003 211 214
54. P. Leutscher, C.E. Ramarokoto, and C.M. Reimert Genital schistosomiasis in males: a community-based study from Madagascar Lancet 355 2000 117 118
55. P. Fischer, W. Kipp, and P. Kabwa Onchocerciasis and HIV in Western Uganda: prevalences and treatment with ivermectin Am J Trop Med Hyg 53 1995 171 178
56. E. Sentongo, T. Rubaale, and D.W. Buettner T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1 Parasite Immunol 20 1998 431 439
57. S.A. Tawill, M. Gallin, and K.D. Erttmenn Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seronegative onchocerciasis patients Trans R Soc Trop Med Hyg 90 1996 85 89
58. R. Gopinath, M. Ostrowski, and S.J. Justement Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro J Infect Dis 182 2000 1804 1808
59. J.E. Fincham, M.B. Markus, and V.J. Adams Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic? Acta Trop 86 2003 315 333
60. O. Shapira Nahor, A. Kalinkovich, and Z. Weisman Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immuno-activated individuals AIDS 12 1998 1731 1733
61. Z. Bentwich, A. Kalinkovich, and Z. Weisman Immune activation is a dominant factor in the pathogenesis of African AIDS Immunol Today 16 1995 187 191
62. Z. Bentwich, A. Kalinkovich, and Z. Weisman Immune activation in the context of HIV infection Clin Exp Immunol 111 1998 1 2
63. A. Kalinkovich, Z. Weisman, and J. Greenberg Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection Clin Exp Immunol 114 1998 414 421
64. Z. Bentwich, G. Maartens, and D. Torten Concurrent infections and HIV pathogenesis AIDS 14 2000 2071 2081